Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
109.7 USD | -2.03% | -0.87% | -10.78% |
05-13 | US reclassification could drive fresh research funding into pot sector | RE |
05-07 | Jazz Pharmaceuticals Insider Sold Shares Worth $548,250, According to a Recent SEC Filing | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.78% | 6.92B | |
+35.01% | 709B | |
+30.61% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.17% | 239B | |
+9.38% | 211B | |
-3.27% | 203B | |
+10.77% | 171B |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- Transcript : Jazz Pharmaceuticals plc, Q2 2022 Earnings Call, Aug 03, 2022